Skip to main content

Table 1 Baseline characteristics of POSEIDON group3 and group 4

From: Intra-ovarian platelet-rich plasma administration plus successive accumulated embryo transfer could be a promising strategy for poor ovarian response management: a before-after study

Variables

All Patients

POSEIDON 3

POSEIDON 4

P-value

PORs (n)

49

13

36

 

Age (years)

37.67 ± 4.15

32.38 ± 1.55

39.58 ± 2.88

< 0.0001

BMI

21.52 ± 2.80

22.35 ± 1.08

21.22 ± 0.38

0.22

LH (IU/L)

Before PRP

5.15 ± 0.59

5.39 ± 0.49

0.79

FSH (IU/mL)

Before PRP

14.05 ± 2.42

14.75 ± 1.30

0.79

Estradiol (pg/mL)

Before PRP

47.68 ± 18.15

36.59 ± 4.20

0.39

AMH (ng/mL)

Before PRP

0.42 ± 0.11

0.41 ± 0.05

0.91

AFC

Before PRP

1.54 ± 0.27

2.19 ± 0.23

0.12

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us